Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclerosis
Dariush Ahrabian1, Lorna Neill1, Robert Bell1
1National Hospital for Neurology and Neurosurgery, UCLH NHS Foundation Trust, London, UK.
Abstract:
Alemtuzumab infusion is rarely associated with serious cardiac toxicity. We report a case of acute troponin-negative chest pain with dynamic T-wave changes, immediately following first infusion of alemtuzumab in a patient with multiple sclerosis. The chest pain and ECG (electrocardiogram) changes improved with cessation of alemtuzumab and conservative management. The presumed cause was infusion-associated cytokine release, but the precise mechanism is unknown.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiopulmonary Resuscitation IV: Pharmacological Management
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care


